Department of General Surgery, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.
Langenbecks Arch Surg. 2022 Sep;407(6):2205-2216. doi: 10.1007/s00423-022-02600-x. Epub 2022 Jul 2.
Blood typing, or group and save (G&S) testing, is commonly performed prior to cholecystectomy and appendectomy in many hospitals. In order to determine whether G&S testing is required prior to these procedures, we set out to evaluate the relevant literature and associated rates of perioperative blood transfusion.
Studies from January 1990 to June 2021 assessing the requirement of preoperative G&S testing for elective or emergency cholecystectomy and appendectomy were retrieved from MEDLINE, EMBASE and CINAHL databases. The search was performed on 6th July 2021 (PROSPERO registration number CRD42021267967). Number of patients, co-morbidities, operation performed, number of patients that underwent preoperative G&S testing, perioperative transfusion rates and financial costs were extracted.
We initially screened 194 studies of which 15 retrospective studies, a total of 477,437 patients, specifically met the inclusion criteria. Ten studies reported on cholecystectomy, two studies on appendectomy and three studies included both procedures. Where reported, a total of 177,539/469,342 (37.8%) patients underwent preoperative G&S testing with a perioperative transfusion rate of 2.1% (range 0.0 to 2.1%). The main preoperative risk factors associated with perioperative blood transfusion identified include cardiovascular co-morbidity, coagulopathy, anaemia and haematological malignancy. All 15 studies concluded that routine G&S is not warranted.
The current evidence suggests that G&S is not necessarily required for all patients undergoing cholecystectomy or appendectomy. Having a targeted G&S approach would reduce delays in elective and emergency lists, reduce the burden on the blood transfusion service and have financial implications.
血型鉴定或群体和保存(G&S)检测在许多医院中常用于胆囊切除术和阑尾切除术之前。为了确定这些手术前是否需要进行 G&S 检测,我们着手评估相关文献和相关围手术期输血率。
从 1990 年 1 月至 2021 年 6 月,我们从 MEDLINE、EMBASE 和 CINAHL 数据库中检索了评估择期或急诊胆囊切除术和阑尾切除术术前 G&S 检测需求的研究。检索于 2021 年 7 月 6 日进行(PROSPERO 注册号 CRD42021267967)。提取患者数量、合并症、手术类型、接受术前 G&S 检测的患者数量、围手术期输血率和财务成本。
我们最初筛选了 194 项研究,其中 15 项回顾性研究,共计 477,437 名患者,符合纳入标准。10 项研究报告了胆囊切除术,2 项研究报告了阑尾切除术,3 项研究包括了这两种手术。报告显示,共有 177,539/469,342(37.8%)名患者接受了术前 G&S 检测,围手术期输血率为 2.1%(范围为 0.0 至 2.1%)。确定的与围手术期输血相关的主要术前危险因素包括心血管合并症、凝血功能障碍、贫血和血液系统恶性肿瘤。所有 15 项研究均得出结论,常规 G&S 不一定适用于所有接受胆囊切除术或阑尾切除术的患者。采用有针对性的 G&S 方法可以减少择期和急诊名单的延迟,减轻输血服务的负担,并产生财务影响。
目前的证据表明,并非所有接受胆囊切除术或阑尾切除术的患者都一定需要进行 G&S 检测。采用有针对性的 G&S 方法可以减少择期和急诊手术名单的延迟,减轻输血服务的负担,并具有经济意义。